Improved serologic detection of hepatitis C virus with a paramagnetic microparticle assay using multiple antigenic...

Area of Science:

• Hepatology
• Immunology
• Biotechnology

Background:

• Hepatitis C virus (HCV) infection is a significant global health concern.
• Accurate and sensitive diagnostic assays are crucial for HCV detection and management.
• Current diagnostic methods may have limitations in sensitivity and early detection.

Purpose of the Study:

• To develop and evaluate a novel paramagnetic microparticle (MP) assay for detecting antibodies to hepatitis C virus (anti-HCV).
• To assess the performance of the MP assay using synthetic peptides and recombinant proteins targeting different HCV regions.
• To compare the diagnostic performance of the MP assay with existing enzyme-linked immunosorbent assay (ELISA) methods.

Main Methods:

• Development of a paramagnetic microparticle (MP) assay using synthetic peptides (HCV capsid, nonstructural c-100) and a recombinant protein (nonstructural c33c).
• Testing of serum samples from 108 patients with non-A, non-B hepatitis (NANBH) and 825 volunteer donors.
• Comparison of MP assay results with a c-100 HCV ELISA and a second-generation anti-HCV ELISA.

Main Results:

• The MP assay detected anti-HCV in 91% of NANBH patients, significantly higher than the 70% detected by c-100 ELISA.
• All specimens positive by c-100 ELISA were also positive by the MP assay.
• The MP assay identified seroconversion 1-2 blood collection dates earlier than the c-100 ELISA in three plasma donors.
• Reactivity patterns indicated that combining multiple HCV antigens enhances detection.

Conclusions:

• The developed paramagnetic microparticle assay is a sensitive and effective tool for detecting antibodies to hepatitis C virus.
• The inclusion of multiple HCV antigens (capsid, c-100, c33c) improves assay performance and early detection capabilities.
• Paramagnetic microparticle technology shows significant promise for advancing serologic testing in HCV diagnostics.